Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?

Modern Pathology

Volumn 11, Issue 3, 1998, Pages 259-264

  Jacobs, Timothy W ^a   Siziopikou, Kalliopi P ^a   Prioleau, John E ^a   Raza, Sughra ^a   Baum, Janet K ^a   Hayes, Daniel F ^a,b   Schnitt, Stuart J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Breast carcinoma; c erbB 2; Core needle biopsy; Estrogen receptor; Microvessel density; p53

Indexed keywords

ESTROGEN RECEPTOR; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P53; VON WILLEBRAND FACTOR;

ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; EXCISION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MASTECTOMY; MICROVASCULATURE; PRIORITY JOURNAL;

BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA; CYTODIAGNOSIS; ENDOTHELIUM, VASCULAR; FACTOR VIII; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031888371     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pettine S, Place R, Babu S, Williard W, Kim D, Carter P. Stereotactic breast biopsy is accurate, minimally invasive, and cost effective. Am J Surg 1996;171:474-6.
2. Wallace JE, Sayler C, McDowell NG, Moseley HS. The role of stereotactic biopsy in assessment of nonpalpable breast lesions. Am J Surg 1996;172:471-3.
3. Yim JH, Barton P, Weber B, Radford D, Levy J, Monsees B, Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy. Annu Surg 1996;223:688-700.
4. Calais G, Descamps P, Chapet S, Turgeon V, Reynaud-Bougnoux A, Lemarié E, et al. Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancer. Int J Radiat Oncol Biol Phys 1993;26:37-42.
5. Schwartz GF, Birchansky CA, Komarnicky LT, Mansfield CM, Cantor RI, Biermann WA, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinomas of the breast. Cancer 1994;73:362-9.
6. Perez CA, Graham ML, Taylor ME, Levy JF, Mortimer JE, Philpott GW, et al. Management of locally advanced carcinoma of the breast. I. Noninflammatory. Cancer 1994;74: 453-65.
7. Harris L, Swain SM. The role of primary chemotherapy in early breast cancer. Semin Oncol 1996;23(Suppl 2):31-42.
8. Honkoop AH, Pinedo HM, De Jong JS, Verheul HMW, Linn SC, Hoekman K, et al. Effects of chemotherapy on pathologic and biologic characteristics of locally advanced breast cancer. Am J Clin Pathol 1997;107:211-8.
9. Kennedy S, Merino MJ, Swain SM, Lippman ME. The effects of hormonal and chemotherapy on tumoral and non-neoplastic breast tissue. Hum Pathol 1990;21:192-8.
10. Frierson HF, Fechner RE. Histologic grade of locally advanced infiltrating ductal carcinoma after treatment with induction chemotherapy. Am J Clin Pathol 1994;102:154-7.
11. Seno R, Sparano JA, Fineberg S. Does neoadjuvant chemotherapy (NAC) alter biological markers in locally advanced breast cancer (LABC)? [abstract]. Mod Pathol 1996;9:24A.
12. Rasbridge SA, Gillett CE, Seymour AM, Patel K, Richards MA, Rubens RD, et al. The effects of chemotherapy on morphology, cellular proliferation, apoptosis and oncoprotein expression in primary breast carcinoma. Br J Cancer 1994;70: 335-41.
13. Poller DN, Roberts EC, Bell JA, Elston CW, Blarney RW, Ellis IO. p53 protein expression in mammary duct carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum Pathol 1993;24: 463-8.
14. Dosaka-Akita H, Shindoh M, Fujino M, Kinoshita I, Akie K, Katoh M, et al. Abnormal p53 expression in human lung cancer associated with histologic subtypes and patient smoking history. Am J Clin Pathol 1994;102:660-4.
15. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen S, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 1994;331:1259-64.
16. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
17. Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology 1993;188:453-5.
18. Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA. Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer and atypical hyperplasia. Radiology 1994;193:91-5.
19. Parker SH, Burbank F, Jackman RJ, Aucreman CJ, Cardenosa G, Cink TM, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology 1994;193:359-64.
20. Richardson A, Chandra R, Lester S. Stereotactic large core needle biopsy of breast carcinomas: correlation of histologic features with 77 matched surgical excisions [abstract]. Mod Pathol 1996;9:23A.
21. Di Loreto C, Puglisi F, Rimondo G, Zuiani C, Anania G, Della Mea V, et al. Large core biopsy for diagnostic and prognostic evaluation of invasive breast carcinomas. Eur J Cancer 1996; 32A:1693-1700.
22. Berezowski K, Grimes MM, Wakely PE Jr. Correlation of histologic grading of infiltrating duct breast cancer in stereotactic core biopsies with subsequent surgical specimens [abstract]. Mod Pathol 1997;10:16A.
23. De Jong JS, van Diest PJ, Baak JP. Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest 1995;73:922-6.
24. Daidone MG, Orefice S, Mastore M, Santoro G, Salvadori B, Silverstrini R. Comparing core needle to surgical biopsies in breast cancer for cell kinetic and ploidy studies. Breast Cancer Res Treat 1991;19:33-7.
25. Nath ME, Robinson TM, Tobon H, Chough DM, Sumkin JH. Automated large-core needle biopsy of surgically removed breast lesions: comparison of samples obtained with 14-, 16-, and 18-gauge needles. Radiology 1995;197:739-42.